Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections

Informazioni relative al progetto

COMBACTE-CDI

ID dell’accordo di sovvenzione: 777362

DOI

10.3030/777362

Progetto chiuso

Data della firma CE 27 Ottobre 2017

Data di avvio 1 Novembre 2017

Data di completamento 30 Aprile 2021

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale

€ 4 179 307,00

Contributo UE

€ 2 312 305,00

Coordinato da

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Netherlands

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (14)

Report on cost/benefit analysis
Results of the cost exercise
Report on heterogeneity of testing and delivery of dataset
Report on status of posting results

Report on the status of posting results in the study registry/ies (including timelines when final posting of results is scheduled after end of funding period).

Report on current guidelines for diagnosis, management and control of CDI
Report on high risk groups and delivery of dataset
Report to map stakeholders and their potential role in COMBACTE-CDI
Report on strain distribution and delivery of dataset
Full ethical approval of final study protocol from all countries
Delivery of completed transmission model
Report on current treatment pathways
Proposal of governance of a pan-European network to study CDI
Report on recurrent CDI, morbidity and mortality and delivery of dataset
Report on current surveillance practices

Websites, patent fillings, videos etc. (1)

Adaptation of COMBACTE website to include COMBACTE-CDI

Pubblicazioni

Peer reviewed articles (1)

Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile

Autori: Ilse M Boekhoud, Igor Sidorov, Sam Nooij, Céline Harmanus, Ingrid M J G Bos-Sanders, Virginie Viprey, William Spittal, Emma Clark, Kerrie Davies, Jane Freeman, Ed J Kuijper, Wiep Klaas Smits, Marc Bonten, Kerrie A Davies, Ed J Kuijper, Maja Rupnik, Sebastian Wingen-Heiman, Evelina Tacconelli, Tuba Wilken, Nicolla Petrosillo, Marc Bonten, Philippe Cleuziat, Chris Webber, Mark Wilcox
Pubblicato in: Journal of Antimicrobial Chemotherapy, 2021, ISSN 0305-7453
Editore: Oxford University Press
DOI: 10.1093/jac/dkab097